| Ronald A Shockley, MD | |
|
3483 S Eastern Ave, Las Vegas, NV 89169-3314 | |
| (702) 309-2311 | |
| (702) 309-2177 |
| Full Name | Ronald A Shockley |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 29 Years |
| Location | 3483 S Eastern Ave, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275511263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 9492 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurses Of Nevada, Inc | Las vegas, NV | Home health agency |
| Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
| Mountainview Hospital | Las vegas, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hope Horizon Family Health Care Llc | 0547682494 | 2 |
| Ronald A Shockley Md A Professional Corporation | 7810094976 | 6 |
News Archive
Advancements in technology and universal acceptance of the Internet have paved the way for major improvements in the healthcare industry. According to a recent report released by PricewaterhouseCooper's Health Research Institute in August 2009, 1.2 trillion healthcare dollars are wasted each year, with two of the main culprits being administrative inefficiency and redundant care.
Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required.
By continuously monitoring the body temperature of mice that had undergone bone-marrow transplants, researchers were able to detect early warning signs of graft-versus-host disease - a dangerous, sometimes deadly response of the transplanted immune system - in a simple, non-invasive way.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 5 days ago
| Entity Name | Ronald A Shockley Md A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861539652 PECOS PAC ID: 7810094976 Enrollment ID: O20070524000210 |
News Archive
Advancements in technology and universal acceptance of the Internet have paved the way for major improvements in the healthcare industry. According to a recent report released by PricewaterhouseCooper's Health Research Institute in August 2009, 1.2 trillion healthcare dollars are wasted each year, with two of the main culprits being administrative inefficiency and redundant care.
Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required.
By continuously monitoring the body temperature of mice that had undergone bone-marrow transplants, researchers were able to detect early warning signs of graft-versus-host disease - a dangerous, sometimes deadly response of the transplanted immune system - in a simple, non-invasive way.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 5 days ago
| Entity Name | Hope Horizon Family Health Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346861499 PECOS PAC ID: 0547682494 Enrollment ID: O20200622002527 |
News Archive
Advancements in technology and universal acceptance of the Internet have paved the way for major improvements in the healthcare industry. According to a recent report released by PricewaterhouseCooper's Health Research Institute in August 2009, 1.2 trillion healthcare dollars are wasted each year, with two of the main culprits being administrative inefficiency and redundant care.
Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required.
By continuously monitoring the body temperature of mice that had undergone bone-marrow transplants, researchers were able to detect early warning signs of graft-versus-host disease - a dangerous, sometimes deadly response of the transplanted immune system - in a simple, non-invasive way.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ronald A Shockley, MD 3483 S Eastern Ave, Las Vegas, NV 89169-3314 Ph: (702) 309-2311 | Ronald A Shockley, MD 3483 S Eastern Ave, Las Vegas, NV 89169-3314 Ph: (702) 309-2311 |
News Archive
Advancements in technology and universal acceptance of the Internet have paved the way for major improvements in the healthcare industry. According to a recent report released by PricewaterhouseCooper's Health Research Institute in August 2009, 1.2 trillion healthcare dollars are wasted each year, with two of the main culprits being administrative inefficiency and redundant care.
Mealtimes can become a difficult experience for individuals with diabetes. After a meal, blood sugar levels may soar as the food digests or unexpectedly plummet if an insulin dose was more than the meal required.
By continuously monitoring the body temperature of mice that had undergone bone-marrow transplants, researchers were able to detect early warning signs of graft-versus-host disease - a dangerous, sometimes deadly response of the transplanted immune system - in a simple, non-invasive way.
Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.
Up to 50% of deaths from cardiovascular disease in Europe could be avoided by implementing population level changes such as taxation and regulation of advertising. Population level prevention will produce greater impacts on CVD than individualised approaches, according to the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) of the European Society of Cardiology (ESC).
› Verified 5 days ago
Dr. Arshi A. Quadeer, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |